ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.

Slides:



Advertisements
Similar presentations
HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):
Advertisements

HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2010 CIBMTR Summary Slides SUM10_1.ppt.
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation 2011 Summary Slides Worldwide SUM-WW11_1.ppt.
Optimizing lung transplant outcomes in the adult and pediatric patient. Cynthia S. Herrington, MD Associate Professor of Surgery Keck School of Medicine.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
Heart Transplantation for Patients with a Fontan Procedure
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
Liver Transplantation Philip Goodney, MD June 22, 2005.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2012 J Heart Lung Transplant Oct; 31(10):
CHAPTER 4 LIVER TRANSPLANTATION Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way.
Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
12/2013 The Present Evolution of Liver Transplantation in Europe EUROPEAN LIVER TRANSPLANT REGISTRY 28 countries institutions 118,441 transplantations.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
Liver Transplantation
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
HEART TRANSPLANTATION Pediatric Recipients 2014 JHLT Oct; 33(10):
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
Professor Nigel Heaton Kings Health Partners
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
Organ Transplantation. Why is Organ Donation So Important?  There are around 1600 people currently waiting for a transplant in Australia  In 2012, 354.
Liver Seminar for Health Plan Case Managers September 23, 2008 October 2, 2008.
HEALTH RESEARCHES AND INNOVATIONS IN THE REPUBLIC OF BELARUS MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS.
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
Draft Organ Allocation Criteria. Factors affecting Allocation Medical need Length of waiting time: time a illness progressed to a point when transplant.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
The Registry of the International Society for Heart and Lung Transplantation: Thirty- second Official Adult Lung and Heart-Lung Transplantation Report—2015;
Fig 1 Trends in organ donors in the UK, 2000–10
Volume 356, Issue 9230, Pages (August 2000)
HCV & liver transplantation
Introduction to TRANSPLANT APP
Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston
Liver Transplantation: 50 years
Liver only transplants in the UK Question 2: In terms of survival benefit.
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
EUROPEAN LIVER TRANSPLANT REGISTRY
EBMT Activity Survey Teams Patients Transplants
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Risk factors in deceased-donor transplants Risk factor 1988
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Cirrosi scompensata e trapianto di fegato: l’esperienza in real world
Recent Advances in Liver Transplantation
What lessons have we learned in pediatric liver transplantation?
Risk Factors associated with Outcome
Transplantation for alcoholic liver disease
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Current and Future Trends in Liver Transplantation in Europe
Challenges to Liver Transplantation and Strategies to Improve Outcomes
Volume 58, Issue 3, Pages (March 2013)
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States  Ju Dong Yang, Joseph.
Organ transplantation: historical perspective and current practice
Volume 57, Issue 3, Pages (September 2012)
Evolution of liver transplantation for hepatocellular carcinoma
Volume 141, Issue 4, Pages (October 2011)
Liver transplantation in children
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Results of Living Donor Age of Sixth Decade for Adult Liver Transplantation Using a Right Lobe graft Seok-Hwan Kim.
Outcomes in liver transplantation: Does sex matter?
Number of Donors in Australia
Presentation transcript:

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 EUROPEAN LIVER TRANSPLANT REGISTRY 25 countries institutions 85,446 transplantations - 76,818 patients 05/ /

ELTR 12/2008 Evolution of 85,446 Liver Transplantations in Europe

ELTR 12/2008 Evolution of the number of Liver Transplantations reported to the ELTR

ELTR 12/2008 Evolution of the number of Liver Transplantations by Center

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 Graft Survival according to Donor Age in Europe 01/ /2008

ELTR 12/2008 Graft Survival according to Donor Age in Elective Liver Transplantation 01/1988 – 12/2008

ELTR 12/2008 Graft Survival according to Donor Age in Urgent Liver Transplantation 01/ /2008

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 Evolution of Recipient Age 05/1968 – 12/2008

ELTR 12/2008 Patient Survival according to Recipient Age 01/ /2008

ELTR 12/2008 Patient Survival according to Adult Recipient Age 01/ /2008

ELTR 12/2008 Proportion of Pediatric Transplantation by Country 01/ /2008

ELTR 12/2008 Primary Indication of Liver Transplantation in Pediatric Patients 05/ /2008

ELTR 12/2008 Graft Survival according to Children Recipient Age 01/ /2008

ELTR 12/2008 Survival of Children >= 2 yrs according to the Main Indication in Europe 01/ /2008

ELTR 12/2008 Graft Survival according to Adult Recipient Age 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantion in Elderly Patients (>= 60 Years) 01/ /2008

ELTR 12/2008 Survival of Elderly Recipients (>= 60 Years) according to the Main Indication in Europe 01/ /2008

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 * Others :Budd Chiari : 675 Benign liver tumors or Polycystic diseases : 934 Parasitic diseases : 67 Other liver diseases : 533 Primary Diseases leading to Liver Transplantion in Europe 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantion in Europe 01/ /2008

ELTR 12/2008 Evolution of Primary Diseases leading to Liver Transplantation in Europe 05/ /2008

ELTR 12/2008 Primary Diseases leading to Liver Transplantion by Country 01/ /2008

ELTR 12/2008 Primary Diseases leading to Liver Transplantation in Adult Recipients 01/ /2008

ELTR 12/2008 Patient and Graft Survival following Liver Transplantation 05/1968 – 12/2008

ELTR 12/2008 Patient Survival according to the Year of Liver Transplantation

ELTR 12/2008 Patient Survival according to the Indication 01/ /2008

ELTR 12/2008 Patient Survival according to the 1st Indication 01/1988 – 12/2008

ELTR 12/2008 Graft Survival according to the Urgency of Liver Transplantation in Europe 01/ /2008

ELTR 12/2008 Graft Survival according to ABO Compatibility In Elective Liver Transplantation 01/ /2008

ELTR 12/2008 Graft Survival according to ABO Compatibility In Urgent Liver Transplantation 01/ /2008

ELTR 12/2008 Liver Transplantation in Europe Indications in Cirrhosis 01/ /2008

ELTR 12/2008 Evolution of Indications for Cirrhosis in Europe 05/ /2008

ELTR 12/2008 Survival of Patients with Cirrhosis as the First Indication 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantation in Virus related Cirrhosis in Europe 01/ /2008

ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/ /2008

ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/ /2008

ELTR 12/2008 Survival of Patients with Virus related Cirrhosis as the First Indication 01/ /2008

ELTR 12/2008 Liver Transplantation in Europe Indications in Hepato-Biliary Cancers 01/ /2008

ELTR 12/2008 Evolution of Indications for Hepato-Biliary Cancers in Europe 05/ /2008

ELTR 12/2008 Survival of Patients with Liver Cancer as the First Indication 01/ /2008

ELTR 12/2008 Survival of Patients with HCC with and without underlying Cirrhosis 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantation in 6155 Patients with Acute Hepatic Failure 01/ /2008

ELTR 12/2008 Survival of Patients with Acute Hepatic Failure as the First Indication 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantation in 7552 Patients with Cholestatic Diseases 01/ /2008

ELTR 12/2008 Survival of Patients with Cholestatic Diseases as the First Indication 01/ /2008

ELTR 12/2008 Primary Indications of Liver Transplantation in 4542 Patients with Metabolic Diseases 01/ /2008

ELTR 12/2008 Survival of Patients with Metabolic Diseases as the First Indication 01/ /2008

ELTR 12/2008 Indications of Liver Transplantation in 2183 Other liver diseases in Europe 05/ /2008

ELTR 12/2008 Survival of Patients with Other Liver Diseases as the First Indication 01/ /2008

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 Graft Survival in Liver Transplantation only vs Liver Combined to other Organ Transplantation 01/ /2008

ELTR 12/2008 Graft Survival according to the Site of Transplantation in Elective LT 01/ /2008

ELTR 12/2008 Type of Liver Graft in Europe according to the Date of Transplantation

ELTR 12/2008 Graft Survival according to the Type of Graft 01/ /2008

ELTR 12/2008 Graft Survival according to the Type of Graft 01/ /2008

ELTR 12/2008 Graft Survival according to the Type of Graft in Elective Liver Transplantation 01/ /2008

ELTR 12/2008 Graft Survival according to the Type of Graft in Urgent Liver Transplantation 01/ /2008

ELTR 12/2008 Graft Survival according to the Cold Ischemic Time in UW Elective Liver Transplantation 01/ /2008

ELTR 12/2008 Graft Survival according to the Cold Ischemic Time in UW Urgent Liver Transplantation 01/ /2008

ELTR 12/2008 Auxiliary vs Non Auxiliary Graft Survival in Elective Liver Transplantation 01/ /2008

ELTR 12/2008 Auxiliary vs Non Auxiliary Graft Survival in Urgent Liver Transplantation 01/ /2008

ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results 5. Evolution of techniques 6. Mortality and retransplantation

ELTR 12/2008 Liver Transplantation in Europe Mortality and Retransplantation 01/ /2008

ELTR 12/2008 Graft Survival according to the Number of Liver Transplantations in Europe 01/ /2008

ELTR 12/2008 Graft Survival according to the number of the Liver Transplantation in Elective Cases 01/ /2008

ELTR 12/2008 Graft Survival according to the number of the Liver Transplantation in Urgent Cases 01/ /2008

ELTR 12/2008 Patient Survival according to the number of Liver Transplantations 01/ /2008

ELTR 12/2008 Patient Survival according to the number of LTs in Elective cases for the 1st LT 01/ /2008

ELTR 12/2008 Patient Survival according to the number of LTs in Urgent cases for the 1st LT 01/1988 – 12/2008

ELTR 12/2008 Mortality following the 1st LT 01/ /2008

ELTR 12/2008 Causes of Retransplant following the 1st LT 01/ /2008